valsartan has been researched along with Diastolic Heart Failure in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donova, T; Koshtikova, K; Manov, E; Naidenov, S; Rangelov, Y; Runev, N; Shabani, R; Vitlyanova, K | 1 |
| Frantz, S; Hundertmark, M | 1 |
| Einecke, D | 1 |
| Dong, YF; Ichijo, H; Kataoka, K; Kim-Mitsuyama, S; Matsuba, S; Ogawa, H; Shintaku, H; Tokutomi, Y; Yamamoto, E; Yamashita, T | 1 |
1 review(s) available for valsartan and Diastolic Heart Failure
| Article | Year |
|---|---|
[Heart failure: new insights and developments].
Topics: Acute Disease; Aminobutyrates; Biphenyl Compounds; Cardiac Resynchronization Therapy; Combined Modality Therapy; Drug Combinations; Heart Failure, Diastolic; Heart Failure, Systolic; Humans; Prognosis; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Spironolactone; Survival Rate; Tetrazoles; Valsartan | 2014 |
3 other study(ies) available for valsartan and Diastolic Heart Failure
| Article | Year |
|---|---|
Effects of the angiotensin receptor blocker Valsartan (Valsacor®) on arterial pressure, indices of myocardial diastolic function and global longitudinal strain in patients with uncontrolled arterial hypertension.
Topics: Adult; Aged; Aged, 80 and over; Arterial Pressure; Drug Therapy, Combination; Echocardiography; Echocardiography, Doppler; Female; Follow-Up Studies; Heart Failure, Diastolic; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction; Tetrazoles; Valine; Valsartan | 2013 |
[2 promising substances for diastolic heart failure].
Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Drug Combinations; Heart Failure, Diastolic; Humans; Mineralocorticoid Receptor Antagonists; Neprilysin; Spironolactone; Tetrazoles; Valine; Valsartan | 2012 |
Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
Topics: Acetophenones; Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Apoptosis; Biopterins; Blood Pressure; Calcium Channel Blockers; Disease Models, Animal; Endothelium, Vascular; Heart Failure, Diastolic; Hydralazine; Hypertension; Male; MAP Kinase Kinase Kinase 5; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Nitric Oxide Synthase Type III; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Signal Transduction; Sodium Chloride, Dietary; Superoxides; Tetrazoles; Time Factors; Valine; Valsartan; Vasodilation | 2007 |